|
TFE3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.069800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.216400E-02 |
| Normal-vs-Stage2 |
8.066800E-01 |
| Normal-vs-Stage3 |
5.049000E-01 |
| Normal-vs-Stage4 |
2.415900E-02 |
| Stage1-vs-Stage2 |
9.931700E-02 |
| Stage1-vs-Stage3 |
2.378200E-01 |
| Stage1-vs-Stage4 |
1.933360E-01 |
| Stage2-vs-Stage3 |
4.507200E-01 |
| Stage2-vs-Stage4 |
2.571600E-02 |
| Stage3-vs-Stage4 |
6.247600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.286400E-02 |
| Normal-vs-AfricanAmerican |
1.297400E-01 |
| Normal-vs-Asian |
2.196000E-01 |
| Caucasian-vs-AfricanAmerican |
4.606800E-01 |
| Caucasian-vs-Asian |
2.602800E-01 |
| AfricanAmerican-vs-Asian |
2.961600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.294400E-01 |
| Normal-vs-Female |
5.059300E-03 |
| Male-vs-Female |
4.705500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.080600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.019800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.704370E-01 |
| Normal-vs-Age(81-100Yrs) |
5.833200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.490800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.278000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.679000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.483400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.711200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.368800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.444400E-04 |
| Normal-vs-Grade 2 |
1.332570E-01 |
| Normal-vs-Grade 3 |
3.035000E-01 |
| Normal-vs-Grade 4 |
1.968450E-02 |
| Grade 1-vs-Grade 2 |
7.115600E-02 |
| Grade 1-vs-Grade 3 |
2.040100E-02 |
| Grade 1-vs-Grade 4 |
5.764600E-01 |
| Grade 2-vs-Grade 3 |
5.581800E-01 |
| Grade 2-vs-Grade 4 |
9.712100E-02 |
| Grade 3-vs-Grade 4 |
5.463600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.655000E-01 |
| Normal-vs-ccB subtype |
4.315700E-02 |
| ccA subtype-vs-ccB subtype |
1.385780E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.770500E-02 |
| Normal-vs-N1 |
1.100840E-01 |
| N0-vs-N1 |
6.315800E-01 |
|
|
